MODULATION OF SURVIVIN EXPRESSION
    1.
    发明申请
    MODULATION OF SURVIVIN EXPRESSION 审中-公开
    SURVIVIN表达调控

    公开(公告)号:US20090203896A1

    公开(公告)日:2009-08-13

    申请号:US12430465

    申请日:2009-04-27

    摘要: Compounds and compositions are provided for modulating the expression of survivin. The compounds, exemplified by those acting through an RNAi antisense mechanism of action, include double-stranded and single-stranded constructs, as well as siRNAs, canonical siRNAs, blunt-ended siRNAs and single-stranded antisense RNA compounds. Methods of using these compounds for modulation of survivin expression and for treatment of diseases associated with expression of survivin are provided.

    摘要翻译: 提供化合物和组合物用于调节存活蛋白的表达。 由通过RNAi反义作用机制起作用的那些实例所列举的化合物包括双链和单链构建体,以及siRNA,典型siRNA,平端siRNA和单链反义RNA化合物。 提供了使用这些化合物调节存活蛋白表达和治疗与存活蛋白表达相关的疾病的方法。

    Modulation of survivin expression
    2.
    发明授权
    Modulation of survivin expression 失效
    生存素表达调控

    公开(公告)号:US07541344B2

    公开(公告)日:2009-06-02

    申请号:US10559636

    申请日:2004-06-03

    摘要: Compounds and compositions are provided for modulating the expression of survivin. The compounds, exemplified by those acting through an RNAi antisense mechanism of action, include double-stranded and single-stranded constructs, as well as siRNAs, canonical siRNAs, blunt-ended siRNAs and single-stranded antisense RNA compounds. Methods of using these compounds for modulation of survivin expression and for treatment of diseases associated with expression of survivin are provided.

    摘要翻译: 提供化合物和组合物用于调节存活蛋白的表达。 由通过RNAi反义作用机制起作用的那些实例所列举的化合物包括双链和单链构建体,以及siRNA,典型siRNA,平端siRNA和单链反义RNA化合物。 提供了使用这些化合物调节存活蛋白表达和治疗与存活蛋白表达相关的疾病的方法。

    Oligomeric Compounds That Facilitate Risc Loading
    3.
    发明申请
    Oligomeric Compounds That Facilitate Risc Loading 审中-公开
    促进Risc加载的低分子化合物

    公开(公告)号:US20070275921A1

    公开(公告)日:2007-11-29

    申请号:US11569929

    申请日:2005-06-02

    CPC分类号: A61K31/7052

    摘要: The present invention provides double stranded compositions wherein one of the strands is useful in, for example, influencing the preferential loading the opposite strand into the RISC (or cleavage) complex. In particular, the present invention provides oligomeric compounds that comprise chemical modifications in at least one of the strands to drive loading of the opposite strand into the RISC (or cleavage) complex. Such modifications can be used to increase potency of duplex constructs that have been modified to enhance stability. Examples of chemical modifications that drive loading of the second strand include, but are not limited to, MOE (2′-O(CH2)2OCH3), 2′-O-methyl, -ethyl, -propyl, and —N-methylacetamide. Such modifications can be distributed throughout the strand, or placed at the 5′ and/or 3′ ends to make a gapmer motif on the sense strand. The activity of the 4′-thio gapmer RNA antisense strand can be improved by incorporating alternating MOE or MOE gapmer motif into the sense strand.

    摘要翻译: 本发明提供双链组合物,其中一条链可用于例如影响相对链优先加载到RISC(或切割)复合物中。 特别地,本发明提供了在至少一个链中包含化学修饰以驱动相反链加载到RISC(或切割)复合物中的低聚化合物。 可以使用这些修饰来增加经修饰以增强稳定性的双链构建体的效力。 驱动第二链的负载的化学修饰的实例包括但不限于MOE(2'-O(CH 2)2 OCH 3) ,2'-O-甲基, - 乙基, - 丙基和-N-甲基乙酰胺。 这样的修饰可以分布在整个链上,或者放置在5'和/或3'末端以在有义链上形成gapmer基序。 通过将交替的MOE或MOE gapmer基序并入有义链中,可以改善4'-硫代间隔RNA反义链的活性。

    Modulation of survivin expression
    7.
    发明申请
    Modulation of survivin expression 失效
    生存素表达调控

    公开(公告)号:US20070161547A1

    公开(公告)日:2007-07-12

    申请号:US10559636

    申请日:2004-06-03

    IPC分类号: A61K48/00 C07H21/02

    摘要: Compounds and compositions are provided for modulating the expression of survivin. The compounds, exemplified by those acting through an RNAi antisense mechanism of action, include double-stranded and single-stranded constructs, as well as siRNAs, canonical siRNAs, blunt-ended siRNAs and single-stranded antisense RNA compounds. Methods of using these compounds for modulation of survivin expression and for treatment of diseases associated with expression of survivin are provided.

    摘要翻译: 提供化合物和组合物用于调节存活蛋白的表达。 由通过RNAi反义作用机制起作用的那些实例所列举的化合物包括双链和单链构建体,以及siRNA,典型siRNA,平端siRNA和单链反义RNA化合物。 提供了使用这些化合物调节存活蛋白表达和治疗与存活蛋白表达相关的疾病的方法。